Rift Valley Fever

Newly identified natural protein blocks HIV, other deadly viruses

A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah ...

HIV & AIDS created Feb 11, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Discovery advances fight against phleboviruses

(Medical Xpress)—Researchers in the Life Sciences Institute at the University of Michigan have discovered how a particular type of virus hides and protects its genetic information from the immune system, ...

Medical research created Nov 07, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

New approach needed to tackle emerging zoonotic diseases

(Medical Xpress)—A more coordinated approach to surveillance is required if emerging diseases which can spread from animals to humans are to be tackled, say scientists.

Diseases, Conditions, Syndromes created Sep 10, 2012 | popularity not rated yet | comments 0

New study maps hotspots of human-animal infectious diseases and emerging disease outbreaks

A new global study mapping human-animal diseases like tuberculosis (TB) and Rift Valley fever finds that an "unlucky" 13 zoonoses are responsible for 2.4 billion cases of human illness and 2.2 million deaths per year. The ...

Diseases, Conditions, Syndromes created Jul 04, 2012 | popularity not rated yet | comments 0

Building a better Rift Valley fever vaccine

University of Texas Medical Branch researchers have significantly improved an existing experimental vaccine for Rift Valley fever virus, making possible the development of a more effective defense against the dangerous mosquito-borne ...

Medical research created Jun 27, 2012 | popularity not rated yet | comments 0 | with audio podcast

New genetically engineered vaccines target Rift Valley fever

(PhysOrg.com) -- Researchers from the University of California, Davis, and elsewhere are reporting the development of two genetically engineered vaccines to combat the mosquito-borne Rift Valley fever, devastating ...

Diseases, Conditions, Syndromes created Aug 24, 2011 | popularity not rated yet | comments 0 | with audio podcast

East Africa and Middle East seek plan to keep animal diseases from disrupting livestock trade

With increased trade in livestock products offering a possible antidote to high food prices, livestock experts from the Middle East and 12 African countries are meeting this week in Dubai to develop a strategy that eliminates ...

Diseases, Conditions, Syndromes created Jun 14, 2011 | popularity not rated yet | comments 0


Rift Valley fever (RVF) is a viral zoonosis (affects primarily domestic livestock, but can be passed to humans) causing fever. It is spread by the bite of infected mosquitoes, typically the Aedes or Culex genera. The disease is caused by the RVF virus, a member of the genus Phlebovirus (family Bunyaviridae). The disease was first reported among livestock in Kenya around 1915, but the virus was not isolated until 1931. RVF outbreaks occur across sub-Saharan Africa, with outbreaks occurring elsewhere infrequently, but sometimes severely. In Egypt in 1977-78, several million people were infected and thousands died during a violent epidemic. In Kenya in 1998, the virus claimed the lives of over 400 Kenyans. In September 2000, an outbreak was confirmed in Saudi Arabia and Yemen). On 19 Oct 2011, the first confirmed human case of Rift Valley fever contracted in Zimbabwe was reported in a Caucasian female traveler who returned to France after a 26-day stay in Marondera, Mashonaland East Province during July and August, 2011.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

Are kids who take music lessons different from other kids?

(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...

New discovery in fight against deadly meningococcal disease

Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.

Pay attention: How we focus and concentrate

Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.

Study reveals active site of enzyme linked to stuttering

(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...

Cold plasma successful against brain cancer cells

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...

Can you put a price on health?

As health services strive to improve quality and reduce costs, researchers study the benefits – and the pitfalls – of 'pay for performance' in hospitals.

Vaccine blackjack: IL-21 critical to fight against viral infections

(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Depression linked to telomere enzyme, aging, chronic disease

(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.

Researchers find possible 'master switch' in deadly brain cancer

(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.